Triazole compounds and uses related thereto

Details for Australian Patent Application No. 2004286836 (hide)

Owner Amgen Inc. Japan Tobacco, Inc.

Inventors Goto, Hiroyuki; Yata, Shinji; Tu, Hua; Matsuda, Isamu; Imamura, Katsuaki; Harada, Kazuhito; Powers, Jay P.; Cardozo, Mario G.; Ohe, Yasuhiro; Kakutani, Makoto

Agent Knightsbridge Patent Attorneys

Pub. Number AU-A-2004286836

PCT Pub. Number WO2005/044192

Priority 60/515,537 28.10.03 US

Filing date 27 October 2004

Wipo publication date 19 May 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/044192 Priority application(s): WO2005/044192

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286838-2-azetidinones as antihypercholesterolemic agents

2004286835-Use of interferon-tau in medecine